Your uveitis story belongs here.
Whether it’s a recent talk you gave, a local workshop you hosted, or just a small moment that made you love this field even more — we want to share it.
DM us your experiences!
Cancer therapies are changing fast… and the eye can tell the story.
Join us for the next Virtual Uveitis Fellows Course with Dr. Meghan Berkenstock on side effects of immunotherapy and targeted cancer agents.
June 9 | 8 PM EST / 5 PM PST
https://t.co/URWE8bPYwy
Have a case you can’t stop thinking about? Share it.
The Young Uveitis Society is launching our first Grand Rounds — and we’re looking for compelling uveitis cases of all kinds.
✨ Trainees especially encouraged
🧠 Present, learn, and connect
Submit your case today!
What does a uveitis career look like beyond clinic?
Join us May 19 for:
“Building a Successful Uveitis Career: From Clinic → Industry”
Featuring Dr. H. Nida Sen (Sanofi R&D)
🗓 8 PM EST / 5 PM PST
🔗 Register: https://t.co/Ux2hdnBIbA
#Uveitis#Ophthalmology#MedEd#Retina
We are looking for manuscript reviewers for Journal of Ocular Immunology and Inflammation (impact factor 2.0, 2024)
If you are interested or have any questions, please reach out to John Gonzales: [email protected]
Don’t miss this.
Dr. Anita Agarwal | April 20
Masquerade syndromes in uveitis
A focused session on the diagnoses you don’t want to miss.
🔗 https://t.co/a433fyf0qY
Join us for a focused, case-based deep dive into infectious uveitis covering diagnostic clues, imaging pearls, and evidence-based management you can use immediately in clinic.
🗓 Monday, January 26, 2026
⏰ 8 PM EST / 5 PM PST
🔗 Register here:
https://t.co/btmYk2vJJ1
#Uveitis
RCT: Suppressive valacyclovir treatment for herpes zoster ophthalmicus did not show a significant benefit at 12 months but demonstrated clinically relevant benefits at 18 months. https://t.co/TOFumd8HlU
CMV anterior #uveitis can be difficult to diagnose. Clinical features include elevated #IOP, AC inflammation, iris atrophy, endotheliitis and, circinate keratic precipitates (KPs) or KP corrals. #aao#ophthalmology https://t.co/hT8LN6zPl5
How should ophthalmologists treat persistent or recurrent #uveitic macular edema? Register now for the #Ophthalmology Virtual Journal Club to hear from experts Gary N. Holland, MD, & @EdmundTsuiMD, on 4/23. Exclusive for Academy Members. https://t.co/eDGrHQniQ3
Why join the Young Uveitis Specialists?
Because mentorship, community, and education matter. At YUS, you’ll find case discussions that challenge you, meetings that connect you, and workshops that help you grow. This is where passion meets purpose.
Be part of something brighter.
Fresh eyes. Shared purpose. Bold future.
Welcome to the Young Uveitis Specialists — your community for learning, collaboration, and advancing care in uveitis.
Whether you’re navigating fellowship or shaping your early career, this space is built for you.
Medical retina debates! How are you treating uveitic macular edema? Dexamethasone (Arthi Venkat, MD) or triamcinolone acetonide, whether suprachoroid (Kareem Moussa, MD) or intravitreal (Akshay Thomas, MD, MS)? @VitBuckleSoc@YoungMDConnect#wildwildVBS#retina
Register for the next #Ophthalmology Journal Club on April 23, free for @aao_ophth members. Gary Holland & @EdmundTsuiMD will discuss “Macular Edema Ranibizumab versus Intravitreal Anti-inflammatory Therapy Trial: 24-Week Outcomes of Uveitic Macular Edema Re-treatment”
https://t.co/13kiApFtAR
Investigate treatment effectiveness in therapeutic interventions to slow autoimmune #retinopathy with Majda Hadziahmetovic, MD & @edmundtsuiMD in the latest #Ophthalmology Journal podcast.
Uveitis #CME Webinar on 2/13. Join Dr. Brian Do, uveitis experts, and AUS to learn about the updates in local therapies for non-infectious #uveitis. Free for Academy members. https://t.co/BwaT6PEZ3k